Last updated: March 2, 2026
Sponsor: University of Chicago
Overall Status: Terminated
Phase
N/A
Condition
Rosacea
Soft Tissue Infections
Acne Inversa
Treatment
N/AClinical Study ID
NCT05710393
IRB18-1861
Ages > 7 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants (affected) with Hidradenitis Suppurativa and related symptoms
Family (unaffected) of participants with Hidradenitis Suppurativa
Exclusion
Exclusion Criteria:
- Children under 7-years of age
Study Design
Total Participants: 97
Study Start date:
September 17, 2019
Estimated Completion Date:
February 27, 2026
Study Description
Connect with a study center
University of Chicago Medicine
Chicago, Illinois 60637
United StatesSite Not Available
University of Chicago Medicine
Chicago 4887398, Illinois 4896861 60637
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.